Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy

NCT00999258 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT00999258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy
Lead sponsor
Temple University
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2009
Completion date
June 30, 2011
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic allograft nephropathy, glomerular filtration rate